Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Gate-all-around junctionless FET based label-free dielectric/charge modulation detection of SARS-CoV-2 virus

Kumari Nibha Priyadarshania, Sangeeta Singha and Mustafa K. A. Mohammed*b
aMicroelectronics & VLSI lab, National Institute of Technology, Patna-800005, India. E-mail: nibha@nitp.ac.in; sangeeta.singh@nitp.ac.in
bRadiology Techniques Department, Dijlah University College, Al-Masafi Street, Baghdad 00964, Iraq. E-mail: mustafa_kareem97@yahoo.com

Received 23rd November 2021 , Accepted 17th March 2022

First published on 23rd March 2022


Abstract

The recent corona outbreak has necessitated the development of a label-free, highly sensitive, fast, accurate, and cost-effective biosensor for the detection of SARS-CoV-2 virus. This study records the label-free electrical detection of the SARS-CoV-2 virus using the gate-all-around junctionless field effect transistor (GAA-JLFET) that detects the virus because of the electrical properties (dielectric constant and charge) of spike protein, envelope protein, and virus DNA, for a highly sensitive and real-time bio-sensor. GAA-JLFETs are suitable for this application because of their highest gate controllability, potential vertical stacking, current industry trend compatibility, inherent ease of fabrication, and higher sensitivity. The SARS-CoV-2 virus is first immobilized in the etched nano-cavity embedded beneath the gate electrode, which is then used to detect it. The SARS-CoV-2 virus detection has been calibrated based on the change in system electrical properties after virus immobilization. For effective virus detection, the work takes into account both the dielectric property of S protein and the charge of DNA at the same time. The sensitivity has been calculated using ΔVTH, ΔION, Δgm, and ΔSS. The simulation analysis also shows a simpler recovery mechanism in this case.


1 Introduction

This COVID-19 pandemic has wreaked havoc on society and caused global hysteria. Different zoonotic outbreaks such as Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) in 2002–2003 (ref. 1) and 2012 the Middle East Respiratory Syndrome Coronavirus (MERS-CoV)2 and the current version SARS-CoV-2 are caused by coronavirus only.3 The COVID-19's condition was alarming due to its higher transmission rate and mortality rates as compared to the other deadly viral outbreaks.4–6 The SARS-CoV-2 virus has a spherical form and a lipid-based envelope membrane. Spike protein (S-protein) protrusions and deposits on the envelope protein (E-protein) and membrane protein (M-protein). A nucleocapsid protein (N-protein) surrounds the RNA, the variation in genome sequence is termed as mutation. It can be the result of genetic copying errors during replication of organisms because of exposure to certain chemicals, ionizing radiations, etc. Mutations cause new variations in a species, and cumulative mutations can even lead to the creation of newer species. These mutations could result in virus strains that are more harmful because they are more contagious. The genome of SARS-CoV-2 is made up of more than 30[thin space (1/6-em)]000 units of ribonucleic acid (RNA). Nucleotides are the building blocks of DNA. Coronaviruses have the largest genome of all the RNA virus families. SARS-CoV-2 virus detection is primarily achieved by two methods. The first is a real-time reverse transcription-Polymerase Chain Reaction (rRT-PCR),7–10 and the second is an IgG antibody test using Enzyme Linked Immunosorbent Assays (ELISA). ELISA is a typical procedure for virus detection in which the virus's antibody is found in the patient's blood serum instead of the virus itself.11 The second method is based on the rRT-PCR method, in which the kit detects the E-protein gene, RNA (N-protein), open frame reading b1 (OFRb1), and OFRb2 genes in the internal nasal swab.8 Viruses mutate while transmitting from one medium to another. Various SARS CoV-2 virus mutant have been identified and labeled by WHO as B.1.1.7 (Alpha), B.1.351 (Beta), B.1.617.2 (Delta), P.1 (Gamma), B.1.526 (Iota), B.1.427 (Epsilon), B.1.429 (Epsilon), B.1.617 (Kappa, Delta). These mutants lead to various repercussions such as high transmission rate, increased morbidity, high number of deaths, mutants are able to bypass the diagnostic tests and are not detected, less susceptible to neutralising antibodies, whether therapeutic or laboratory experiments, mutants are able to bypass natural antibody and causes reinfections, mutants are able to infect even after vaccination, it also increases certain risk such as multi-organ inflammatory syndrome or long COVID, higher affinity to distinct groups, such as children or individuals with compromised immunity.12

Detecting the virus and taking precautionary steps are therefore the best measures for the early detection. Furthermore, since there are a limited number of testing kits available and skilled operators are needed, rapid detection of the corona is difficult. At the early stages of virus outbreaks, accurate and rapid diagnosis, as well as successful isolation and care of patients is crucial for the virus containment. This is particularly true when a transmissible disease has no effective cure or fully effective vaccine, as is in this case. Hence, the COVID-19 pandemic has highlighted the importance of leveraging and harnessing our current semiconductor device technology for remote patient detection.13–15 We see a need for more robust disease detection for individual and community health, which could be assisted by existing semi-conductor industry growth for the viral tests as the vaccines are slow to emerge for their new variants.

This work reports the label-free electrical detection of the COVID-virus based on S-protein (dielectric constant) and C-DNA (charge density) by deploying the gate-all-around junctionless field effect transistor (GAA-JLFET). Here highly sensitive and real-time bio-sensors are designed. GAA-JLFETs are the most suitable for this application because of their highest gate controllability, potential vertical stacking, current industry trend compatibility, inherent ease of fabrication, and higher sensitivity. The SARS-CoV-2 virus is first immobilized in an engraved nano-cavity embedded beneath the gate electrode, and then it is used to detect it. The identification of the SARS-CoV-2 virus is now calibrated based on the change in system electrical properties following virus immobilization. The study takes into account both the dielectric property of S protein and the charge on the DNA molecule simultaneously for reliable virus detection. The GAA-JLFET structure can be realized using the process suggested in.16,17 Further, to realize cavity in the device tunnel-etching process can be used.18 In tunnel etching process a SiGe layer is grown on Si substrate and on this layer gate metal contact is grown. This SiGe layer is etched selectively with the help of etchant which has low etching rate and high selectivity for Si, so that it does not damage Si layer. This process needs remote plasma dry etching equipment, which uses fluorocarbon etching gas at high pressure (1500 mT) and low microwave power (200 W).18–21

The following is the organization of the work: the device structural parameters, materials, and doping levels are discussed in Section 2. The effect of cavity thickness variation on bio-sensor sensitivity, as well as sensitivity variation with dielectric modulation and charge density modulation is investigated in Section 3. Section 4 brings the research to a conclusion.

2 Device structure and simulation models

Gate-all-around Junctionless FET (GAA-JLFET) based SARS-CoV-2 virus sensor has been designed because of its single uniform doping, thus easy fabrication and cost-effectiveness. The 3D structure of the GAA-JLFET sensor, 2D cross-sectional view along the xy plane, zy plane, zx plane are shown in Fig. 1(a), (b), (c) and (d), respectively along with its capacitance model for the device in Fig. 1(c) and (d), where CNC shows the capacitance of the nano-cavity, where Cox stands for the capacitance of the oxide layer, and where CDep shows the depletion capacitance of the device. The capacitance model of the device illustrates that the variation in the electrical property of the virus immobilized in the cavity will vary the capacitance of the nano-cavity and this will lead to the change in the device characteristics sensing the virus. The gate length is kept in accordance with the state-of-art technology i.e. 45 nm with work-function of gate electrode considered as 5.93 eV (platinum, Pt). All the device structural parameters are shown in Fig. 1. The doping of silicon region is kept as 1 × 1018 cm−3 of n-type. The cavity region is 15 nm thick under three gates for the immobilization of bio-molecules. Bio-molecule adsorption test is performed during fabrication of sensor by keeping bio-molecule in the cavity till equilibrium between the adsorbed bio-molecule and the bio-molecule in the cavity is reached. A uniform temperature of 25 °C is kept using a thermostat shaker bath. The concentration of bio-molecule present in the solution before and after adsorption is used to calculate the amount of bio-molecule adsorbed. Further, a 5 nm thick SiO2 layer is used for the enhanced binding of the bio-molecules. The study is done by deploying technology computer aided design (TCAD) tool Silvaco ATLAS.22 The drift-diffusion transport model (cvt) is used to model the carrier transport. Concentration dependent and field dependent mobility models are used along with SRH and auger recombination for the precise modeling of carrier recombination. Band gap narrowing model (BGN) is also used. Gummel and newton trap numerical solvers have been used to improve the convergence. Here, the basic bio-molecule detection mechanism is based on the dielectric and charge based modulation effect due to the SARS-CoV-2 virus immobilization in the nano-cavity embedded below the gate electrode.23–27
image file: d1ra08587e-f1.tif
Fig. 1 GAA-JLFET device structure for SARS-CoV-2 virus detection (a) 3D-view and 2-D cross-sectional view along planes, (b) the xy, (c) the zy and its capacitance model to illustrate sensing, and (d) the zx and its capacitance model to illustrate the biosensing.

3 Result and discussion

The dielectric constant of protein protrusions of SARS-CoV-2 virus varies between 2 to 4.13–15,28–31 This property can be utilized for the electrical detection of the virus. Further, the presence of charge density in the DNA of the bio-molecule also provides scope for virus detection based on charge density. In this work, we have studied the detection of viruses based on dielectric modulation as well as charge modulation.32–36

3.1 Sensitivity analysis of S-protein dielectric modulation

In our analysis, we have taken the dielectric constant of SARS-CoV-2 virus as 2 and 4. Fig. 2 shows the potential contour for GAA-JLFET SARS-CoV-2 sensor xz cross-section for the dielectric constant of bio-molecule in the cavity is taken as 1 (air), 2 and 4 for VGS = 1 V and VDS = 1 V. Fig. 3 shows the potential contour for GAA-JLFET SARS-CoV-2 sensor xz cross-section for the dielectric constant of bio-molecule in cavity is taken as 1 (air), 2 and 4 for VGS = 2 V and VDS = 1 V and Fig. 4 shows the potential contour for GAA-JLFET SARS-CoV-2 sensor xz cross-section for the dielectric constant of bio-molecule in the cavity is taken as 1 (air), 2, and 4 for VGS = 3 V and VDS = 1 V. It is observed from the contour plot in Fig. 2 that potential in the device decreases with an increase in the dielectric constant of bio-molecule and in Fig. 3 this difference in potentials decreases with an increase in dielectric constant. Further, in Fig. 4 the potential slightly increases with an increase in the dielectric constant. The surface potential decreases with an increase in the dielectric constant for VGS = 1 V leading to a decrease in drain current and increase in threshold voltage with an increase in the dielectric constant. The decrease in surface potential with an increase in dielectric constant is minimized for VGS = 2 V thus the decrease in drain current with an increase in dielectric constant reduces. Further, the surface potential increases with an increase in dielectric constant for VGS = 3 V leading to increase in drain current with increase in dielectric constant. This drain current behaviour with respect to gate voltage/transfer characteristics are shown in Fig. 5(a) for the variation in the dielectric constant of bio-molecule in the cavity. The threshold voltage of the sensor increases with an increase in the dielectric constant of bio-molecule in the cavity of the sensor. Fig. 5(b) shows the transconductance of the GAA-JLFET sensor with the dielectric constant variation of the bio-molecule. The peak transconductance increases with an increase in the dielectric constant. Here, VTH, ION, ION/IOFF, gm and SSavg of GAA-JLFET sensor with the dielectric constant variation of bio-molecule are listed in Table 1. Further, ΔVTH, ΔION, and Δgm are shown in Fig. 6(a) where ΔVTH, ΔION and Δgm represent the change in VTH, ION and gm with respect to air in the cavity, respectively and is given as
 
ΔVTH = |VTH,κVTH,air| (1)
 
ΔION = |ION,κION,air| (2)
 
Δgm = |gm,κgm,air| (3)

image file: d1ra08587e-f2.tif
Fig. 2 Potential contour for neutral bio-molecule with (a) κ = 1 (air) in the cavity, (b) κ = 2 in the cavity, and (c) κ = 4 in the cavity at VGS = 1 V and VDS = 1 V.

image file: d1ra08587e-f3.tif
Fig. 3 Potential contour for neutral bio-molecule with (a) κ = 1 (air) in the cavity, (b) κ = 2 in the cavity, and (c) κ = 4 in the cavity at VGS = 2 V and VDS = 1 V.

image file: d1ra08587e-f4.tif
Fig. 4 Potential contour for neutral bio-molecule with (a) κ = 1 (air) in the cavity, (b) κ = 2 in the cavity, and (c) κ = 4 in the cavity at VGS = 3 V and VDS = 1 V.

image file: d1ra08587e-f5.tif
Fig. 5 (a) Transfer characteristics and (b) transconductance at VDS = 1 V for the bio-molecules with dielectric constant variations.
Table 1 GAA-JLFET sensor parameters variation with dielectric modulation and charge modulation
  VTH (V) ION (A) ION/IOFF gm (A/V) SSavg (mV per decade)
Dielectric modulation
Air 1.25352 9.9496 × 10−5 3.67972 × 1015 5.51979 × 10−5 97.166
κ = 2 1.39199 1.08027 × 10−4 3.95461 × 1015 6.62049 × 10−5 83.333
κ = 4 1.9701 1.17048 × 10−4 4.27362 × 1015 7.85259 × 10−5 76.666
Charge modulation
− 1 × 1012 3.18357 1.35358 × 10−5 8.49015 × 1014 4.2777 × 10−5 90
− 5 × 1011 2.2574 6.39758 × 10−5 2.02474 × 1015 5.35296 × 10−5 93.33
− 1 × 1011 1.45627 9.394 × 10−5 2.8792 × 1015 5.5072 × 10−5 95.66
0 1.25352 9.9496 × 10−5 3.67972 × 1015 5.51979 × 10−5 97.166
1 × 1011 1.04988 1.04461 × 10−4 9.1356 × 1015 5.5294 × 10−5 98.333
5 × 1011 0.22648 1.19824 × 10−4 4.7168 × 1015 5.51121 × 10−5 111.666
1 × 1012 −0.81903 1.32565 × 10−4 2.46308 × 1015 5.35667 × 10−5 130



image file: d1ra08587e-f6.tif
Fig. 6 Sensitivity of bio-molecules with dielectric constant variation in terms of (a) ΔVTH, ΔION, and Δgm with reference to air in the cavity and (b) variation in SSavg for bio-molecules with dielectric constant variations.

The SSavg of the sensor also varies with the dielectric constant variation of the bio-molecules. The SSavg of the sensor improves with an increase in the dielectric constant of bio-molecule. Here, SSavg is defined as

 
image file: d1ra08587e-t1.tif(4)

The SSavg plot is shown in Fig. 6(b). Here, ΔVTH is in the range of 0.13 V and 0.24 V, ΔION is in the range of 10−6 A and Δgm is in the range of 10−6 A/V, also the variation of SSavg with variation in dielectric constant ensures good sensitivity with dielectric modulation and thus precise detection of bio-molecule/virus.

3.2 Sensitivity analysis of DNA charge density modulation

The presence of charge density in the DNA of the virus makes it traceable with charge density modulation. The interface trap charge density considered for the study is − 1 × 1012 cm−2 to 1 × 1012 cm−2 with a fixed dielectric constant of bio-molecule, the dielectric constant is 1.

Fig. 7(a)–(c) show the potential contours for GAA-JLFET xz cross-section with bio-molecule charge density taken as 1 × 1011 cm−2, 5 × 1011 cm−2, and 1 × 1012 cm−2, respectively at VGS = 3 V and VDS = 1 V. The flat band voltage decreases with an increase in positive charge (image file: d1ra08587e-t2.tif, where ΔVfb is the change in flat band voltage, Nf is the concentration of trap charge and Cox is oxide capacitance) and thus it leads to an increase in the effective potential (Veff = VGSVfb, where Veff is the effective potential at surface and VGS is gate to source supply voltage).37 The potential contour shows an increase in potential with increase in the positive charge density of bio-molecules. The increase in surface potential with an increase in the positive charge density leads to an increase in the drain current and thus a decrease in threshold voltage as shown in Fig. 8(a). Fig. 8(b) shows the transconductance of GAA-JLFET sensor with the positive charge density variation of bio-molecules. The peak transconductance remains similar with the variation in VGS for peak transconductance with an increase in positive charge density. The increase in the positive charge density leads to a decrease in VGS value for peak transconductance. The VTH, ION, ION/IOFF, gm, and SSavg of GAA-JLFET sensor with the positive charge density variation of bio-molecule is listed in Table 1. Further, ΔVTH and ΔION is shown in Fig. 9(a) where ΔVTH and ΔION denote the change in VTH and ION with respect to the neutral bio-molecule in cavity, respectively and is given as

 
ΔVTH = |VTH,chargeVTH,neutral| (5)
 
ΔION = |ION,chargeION,neutral| (6)


image file: d1ra08587e-f7.tif
Fig. 7 Potential contour for positive charge density variations of bio-molecule in cavity with (a) Nf = 1 × 1011, (b) Nf = 5 × 111, and (c) Nf = 1 × 112 at VDS = 1 V and VGS = 3 V.

image file: d1ra08587e-f8.tif
Fig. 8 (a) Transfer characteristics and (b) transconductance at VDS = 1 V for different positive bio-molecules charges densities.

image file: d1ra08587e-f9.tif
Fig. 9 Sensitivity for different positive bio-molecules charge density in cavity in terms of (a) ΔVTH and ΔION with reference to neutral bio-molecule in the cavity and (b) variation in SSavg for different positive bio-molecule charge densities.

The SSavg of the sensor also varies with the positive charge density variation of bio-molecule. The SSavg of the sensor degrades with an increase in the positive charge density of bio-molecule. The SSavg plot is shown in Fig. 9(b). The ΔVTH is in the range of 1–2 V and ΔION is in the range of 10−5 A, also the variation of SSavg with variation in positive charge density ensures good sensitivity with positive charge density and thus precise detection of virus.

Fig. 10(a)–(c) show potential contour for GAA-JLFET xz cross-section with bio-molecule charge density is considered as −1 × 1011 cm−2, −5 × 1011 cm−2, and −1 × 1012 cm−2 respectively at VGS = 3 V and VDS = 1 V. The flat band voltage increases with an increase in negative charge and thus it leads to decrease in effective potential.37 The potential contour shows a decrease in potential with an increase in negative charge density of the bio-molecules. The decrease in surface potential with an increase in the negative charge density leads to a decrease in the drain current and thus an increase in threshold voltage as shown in Fig. 11(a). Fig. 11(b) shows the transconductance of GAA-JLFET sensor with negative charge density variation of bio-molecules. The peak transconductance remains similar to the variation in VGS for peak transconductance with an increase in negative charge density. The increase in negative charge density leads to an increase in VGS value for peak transconductance. The VTH, ION, ION/IOFF, gm, and SSavg of GAA-JLFET sensor with the negative charge density variation of bio-molecule are listed in Table 1. Further, ΔVTH and ΔION are shown in Fig. 12(a) where ΔVTH and ΔION represent the change in VTH and ION with respect to neutral bio-molecule in the cavity, respectively and as given by eqn (5) and (6). The SSavg of the sensor also varies with the negative charge density variation of bio-molecule. The SSavg of the sensor improves with an increase in negative charge density of bio-molecule. The SSavg plot is shown in Fig. 12(b). The ΔVTH is in the range of 1–2 V and ΔION in the range of 10−5 A, also the variation of SSavg with variation in negative charge density ensures good sensitivity with negative charge density and thus precise detection of virus.


image file: d1ra08587e-f10.tif
Fig. 10 Potential contour for negative charge density variation of bio-molecule in cavity with (a) Nf = − 1 × 1011, (b) Nf = − 5 × 111, and (c) Nf = − 1 × 112 at VDS = 1 V and VGS = 3 V.

image file: d1ra08587e-f11.tif
Fig. 11 (a) Transfer characteristics and (b) transconductance at VDS = 1 V for different negative bio-molecules charge densities.

image file: d1ra08587e-f12.tif
Fig. 12 Sensitivity for different negative bio-molecules charge densities in cavity in terms of (a) ΔVTH and ΔION with reference to neutral bio-molecule in the cavity and (b) variation in SSavg for different negative bio-molecule charge densities.

4 Conclusion

This work reports the label-free electrical detection of SARS-CoV-2 virus using the gate-all-around junctionless field effect transistor (GAA-JLFET). The study takes into account simultaneously both the dielectric property of S protein and the charge of DNA for detection of the SARS-CoV-2 virus. The sensitivity has been analyzed in terms of ΔVTH, ΔION, Δgm and SS. This higher variation in these electrical parameters helps in realizing highly sensitive biosensors. GAA-JLFET is deployed here owing to its easy fabrication and higher sensitivity due to higher gate controllability with the increased number of gates. The basic mechanism for SARS-CoV-2 virus detection is the immobilization of the virus in the etched nano-cavity embedded beneath the gate electrode. Further, the change in the device's electrical properties post virus immobilization is calibrated for the SARS-CoV-2 virus detection. This study shows very high sensitivity towards DNA charge density. The TCAD investigation pledges for the potentials of this structure for the array-based screening and in vivo bio-species diagnostics.

Conflicts of interest

There are no conflicts to declare.

Notes and references

  1. C. Drosten, S. Gunther, W. preiser, S. Van Der Werf, H. R. Brodt, S. Becker, H. Rabenau, M. Panning, L. Kolesnikova, R. A. Fouchier and A. Berger, Identification of a novel coronavirus in patients with severe acute respiratory syndrome, N. Engl. J. Med., 2003, 348(20), 1967–1976 CrossRef CAS PubMed.
  2. A. M. Zaki, S. van Boheemen, T. M. Bestebroer, A. D. Osterhaus and R. A. Fouchier, Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia, N. Engl. J. Med., 2012, 367(19), 1814–1820 CrossRef CAS PubMed.
  3. X. Ou, Y. Liu, X. Lei, P. Li, D. Mi, L. Ren, L. Guo, R. Guo, T. Chen, J. Hu and Z. Xiang, Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV, Nat. Commun., 2020, 11(1620), 1–12 Search PubMed.
  4. https://www.worldometers.info/coronavirus/.
  5. J. F. Chan, S. Yuan, K. H. Kok, K. K. W. To, H. Chu, J. Yang, F. Xing, J. Liu, C. C. Y. Yip, R. W. S. Poon and H. W. Tsoi, A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster, Lancet, 2020, 395(10223), 514–523 CrossRef CAS.
  6. Z. Xu, L. Shi, Y. Wang, J. Zhang, L. Huang, C. Zhang, S. Liu, P. Zhao, H. Liu, L. Zhu and Y. Tai, Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Lancet Respir. Med., 2020, 8, 420–422 CrossRef CAS PubMed . www.thelancet.com/respiratory.
  7. C. Giamio, The Spiky Blob Seen Around the World, The New York Times, 2020 Search PubMed.
  8. Smart Detect SARS-CoV-2 rRT-PCR Kit Instructions for Use for Emergency Use Authorization (EUA), pp. 1–18, [https://www.fda.gov/media/136786/download] Search PubMed.
  9. XPRSARS-COV2-10 302-3562, Rev B April 2020 Instructions for Use Under an Emergency Use Authorization (EUA), p. 2020, [https://www.fda.gov/media/136314/download] Search PubMed.
  10. SARS-CoV-2 RNA, Qualitative Real-Time RT-PCR (Test Code 39433) Package Insert For Emergency Use, pp. 1–18, [https://www.fda.gov/media/136231/download] Search PubMed.
  11. Mount Sinai Laboratory COVID-19 ELISA IgG Antibody Test EUA summary, pp. 1–6, [https://www.fda.gov/media/137029/download] Search PubMed.
  12. Emerging SARS-CoV-2 Variants, CDC.gov (Science brief). Centers for Disease Control and Prevention, 28 January 2021 Search PubMed.
  13. M. S. Parihar and A. Kranti, Enhanced sensitivity of double gate junctionless transistor architecture for biosensing applications, Nanotechnology, 2015, 26(14), 1–8,  DOI:10.1088/0957-4484/26/14/145201.
  14. K. Talley, C. Ng, M. Shoppell, P. Kundrotas and E. Alexov, On the electrostatic component of protein-protein binding free energy, PMC Biophys., 2008, 1(1), 2,  DOI:10.1186/1757-5036-1-2.
  15. M. K. Gilson and B. H. Honig, The Dielectric Constant of a Folded Protein, Biopolymers, 1986, 25(11), 2097–2119,  DOI:10.1002/bip.360251106.
  16. Y. Zhang and K. Han, A simulation study of a gate-all-around nanowire transistor with a core–insulator, Micromachines, 2020, 11(2), 223 CrossRef PubMed.
  17. G. Musalgaonkar, S. Sahay, R. S. Saxena and M. J. Kumar, Nanotube tunneling FET with a core source for ultrasteep subthreshold swing: A simulation study, IEEE Trans. Electron Devices, 2019, 66, 4425–4432 CAS.
  18. S. Borel, C. Arvei, J. Bilde, V. Caubet, D. Chanemougame, S. Monfray, R. Ranica, T. Skotnick, Impact of the tunnel etching process on electrical performances of SON devices, Digest of Papers, International Microprocesses and Nanotechnology Conference, 2004 Search PubMed.
  19. M. Jurczak, T. Skotnicki, M. Paoli, B. Tormen, J. Martins, J. L. Regolini, D. Dutartre, P. Ribot, D. Lenoble, R. Pantel and S. Monfray, Silicon-on-nothing (SON)-an innovative process for advanced CMOS, IEEE Trans. Electron Devices, 2000, 47(11), 2179–2187 CrossRef CAS.
  20. I. Mizushima, T. Sato, S. Taniguchi and Y. Tsunashima, Emptyspace-in-silicon technique for fabricating a silicon-on-nothing structure, Appl. Phys. Lett., 2000, 77(20), 3290–3292 CrossRef CAS.
  21. S. Monfray, T. Skotnicki, C. Fenouillet-Beranger, N. Carriere, D. Chanemougame, Y. Morand, S. Descombes, A. Talbot, D. Dutartre, C. Jenny, P. Mazoyer, R. Palla, F. Leverd, Y. Le Friec, R. Pantel, S. Borel, D. Louis and N. Buffet, Emerging silicon-on-nothing (SON) devices technology, Solid-State Electron., 2004, 48(6), 887–895 CrossRef CAS.
  22. ATLAS User Manual, Silvaco International, Santa Clara, CA, 2021 Search PubMed.
  23. R. Narang, M. Saxena and M. Gupta, Investigation of dielectric modulated (DM) double gate (DG) junctionless MOSFETs for application as a biosensors, Superlattices Microstruct., 2015, 85, 557–572 CrossRef.
  24. S. Yadav, A. Gedam and S. Tirkey, A dielectric modulated biosensor for SARS-CoV-2, IEEE Sens. J., 2020 Search PubMed.
  25. G. Wadhwa and B. Raj, Design, Simulation and Performance Analysis of JLTFET Biosensor for High Sensitivity, IEEE Trans. Nanotechnol., 2019, 18, 567–574 CAS.
  26. S. Singh, P. N. Kondekar and N. K. Jaiswal, Label-free biosensor using nanogap embedded dielectric modulated Schottky tunneling source impact ionization MOS, Microelectron. Eng., 2016, 149, 129–134 CrossRef CAS.
  27. G. Wadhwa and B. Raj, Label free detection of biomolecules using charge-plasma-based gate underlap dielectric modulated Junctionless TFET, J. Electron. Mater., 2018, 47(8), 4883–4893 CrossRef.
  28. H. Gouda, I. D. Kuntz, D. A. Case and P. A. Kollman, Free energy calculations for theophylline binding to an RNA aptamer Comparison of MM-PBSA and thermodynamic integration methods, Biopolymers, 2002, 68, 16–34 CrossRef PubMed.
  29. P. A. Kollman, I. Massova, C. Reyes, B. Kuhn, S. Huo, L. Chong, M. Lee, T. Lee, Y. Duan, W. Wang, O. Donini, P. Cieplak, J. Srinivasan, D. A. Case and T. E. Cheatham 3rd, Calculating structures and free energies of complex molecules combining molecular mechanics and continuum models, Acc. Chem. Res., 2000, 33, 889–897 CrossRef CAS PubMed.
  30. D. L. Mobley, K. A. Dill and J. D. Chodera, Treating entropy and conformational changes in implicit solvent simulations of small molecules, J. Phys. Chem. B, 2008, 112, 938–946 CrossRef CAS PubMed.
  31. M. K. Gilson and B. Honig, Calculation of the total electrostatic energy of a macromolecular system: solvation energies, binding energies, and conformational analysis, Proteins: Struct., Funct., Bioinf., 2004, 4, 7–18 CrossRef PubMed.
  32. S. Singh, P. N. Kondekar and N. K. Jaiswal, Comparative Analysis of T-Gate and L-Gate Dielectric Modulated Schottky Tunneling Source Impact Ionization MOS for Label-Free Detection of Toxic Gases, J. Nanoelectron. Optoelectron., 2018, 13(4), 501–508 CrossRef CAS.
  33. R. Narang, M. Saxena, R. S. Gupta and M. Gupta, Dielectric modulated tunnel field-effect transistor—A biomolecule sensor, IEEE Electron Device Lett., 2012, 33(2), 266–268 CAS.
  34. R. Ajay, M. Narang, M. Saxena and M. Gupta, Modeling and simulation investigation of sensitivity of symmetric split gate junctionless FET for biosensing application, IEEE Sens. J., 2017, 17(15), 4853–4861 CAS.
  35. G. Wadhwa and B. Raj, Design, Simulation and Performance Analysis of JLTFET Biosensor for High Sensitivity, IEEE Trans. Nanotechnol., 2019, 18, 567–574 CAS.
  36. G. Wadhwa and B. Raj, Parametric variation analysis of symmetric double gate charge plasma JLTFET for biosensor application, IEEE Sens. J., 2018, 18(15), 6070–6077 CAS.
  37. P. Kumari, A. Raj, K. N. Priyadarshani and S. Singh, Impact of temperature and interface trapped charges variation on the Analog/RF and linearity of vertically extended drain double gate Si0.5Ge0.5 source tunnel FET, Microelectron. J., 2021, 113, 105077 CrossRef CAS.

Footnote

Electronic supplementary information (ESI) available. See DOI: 10.1039/d1ra08587e

This journal is © The Royal Society of Chemistry 2022